R.H. Bluestein & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $413K | Hold |
600
| – | – | 0.03% | 171 |
|
|
2022
Q2 | $355K | Hold |
600
| – | – | 0.02% | 210 |
|
|
2022
Q1 | $419K | Hold |
600
| – | – | 0.02% | 225 |
|
|
2021
Q4 | $379K | Sell |
600
-500
| -45% | -$316K | 0.01% | 257 |
|
|
2021
Q3 | $666K | Sell |
1,100
-500
| -31% | -$303K | 0.03% | 175 |
|
|
2021
Q2 | $894K | Buy |
1,600
+100
| +7% | +$55.9K | 0.03% | 141 |
|
|
2021
Q1 | $710K | Sell |
1,500
-39,417
| -96% | -$18.7M | 0.03% | 148 |
|
|
2020
Q4 | $19.8M | Buy |
40,917
+19,667
| +93% | +$9.5M | 0.88% | 40 |
|
|
2020
Q3 | $11.9M | Buy |
21,250
+810
| +4% | +$453K | 0.6% | 45 |
|
|
2020
Q2 | $12.7M | Buy |
+20,440
| New | +$12.7M | 0.71% | 47 |
|
|
2015
Q4 | – | Sell |
-2,050
| Closed | -$954K | – | 300 |
|
|
2015
Q3 | $954K | Buy |
+2,050
| New | +$954K | 0.07% | 83 |
|
|
2014
Q2 | – | Sell |
-1,300
| Closed | -$390K | – | 378 |
|
|
2014
Q1 | $390K | Buy |
+1,300
| New | +$390K | 0.03% | 228 |
|